Clinical Roundup Imfinzi + tremelimumab significantly improved OS for 1st-line unresectable liver cancer in HIMALAYA phase III trial October 22, 2021Vol.47 No.39
Clinical Roundup EMERALD trial evaluating elacestrant in breast cancer yields positive phase III results October 22, 2021Vol.47 No.39
Clinical Roundup CoImmune, MSK will collaborate on CAR-CIK therapies to treat solid tumors October 22, 2021Vol.47 No.39
Clinical Roundup MSK study supports continued use of telemedicine in oncology October 22, 2021Vol.47 No.39
Drugs & Targets Keytruda + chemo gets EC approval for locally recurrent unresectable or metastatic triple-negative breast cancer October 22, 2021Vol.47 No.39
Drugs & Targets Opdivo + chemo gets EC approval for metastatic gastric cancer, GEJ cancer, or EAC October 22, 2021Vol.47 No.39
Drugs & Targets Point32Health, Takeda enter risk-sharing agreement for Alunbrig in ALK+NSCLC October 22, 2021Vol.47 No.39
Capitol Hill AACR Cancer Progress Report underscores need for continued investment in cancer research October 15, 2021Vol.47 No.38By Alice Tracey
In Brief Madhusmita Behera named chief informatics and data officer at Winship October 15, 2021Vol.47 No.38
